tiprankstipranks
Meds Apotek AB (SE:MEDS)
:MEDS
Sweden Market
MEDS
Meds Apotek AB
RESEARCH TOOLSreports

Meds Apotek AB (MEDS) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

MEDS Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Meds
Apotek AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MEDS Stock 12 Month Forecast

There Are No Analyst Ratings for SE:MEDS In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MEDS Financial Forecast

MEDS Earnings Forecast

Next quarter’s earnings estimate for MEDS is kr0.00 with a range of kr0.00 to kr0.00. The previous quarter’s EPS was kr0.30. MEDS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year MEDS has Performed in-line its overall industry.
Next quarter’s earnings estimate for MEDS is kr0.00 with a range of kr0.00 to kr0.00. The previous quarter’s EPS was kr0.30. MEDS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year MEDS has Performed in-line its overall industry.

MEDS Sales Forecast

Next quarter’s sales forecast for MEDS is kr260.00M with a range of kr256.00M to kr264.00M. The previous quarter’s sales results were kr303.57M. MEDS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year MEDS has Performed in-line its overall industry.
Next quarter’s sales forecast for MEDS is kr260.00M with a range of kr256.00M to kr264.00M. The previous quarter’s sales results were kr303.57M. MEDS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year MEDS has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

MEDS Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

MEDS Stock Forecast FAQ

What is SE:MEDS’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:MEDS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:MEDS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Meds Apotek AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Meds Apotek AB’s share price target?
      Currently, no data Available
      What do analysts say about Meds Apotek AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Meds Apotek AB?
      To buy shares of SE:MEDS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.